Prevention of Pneumococcal Infections: Impact Collaborative Medico-pharmaceutical Care Structured to Improve Vaccination Coverage of Patients at Risk.

Inclusion Criteria

• •The patient must have given their free and informed oral consent
• •The patient must be a member or beneficiary of a health insurance plan
• •The patient is admitted to full hospitalization in a surgical or medical department.
• •The patient will benefit from a reconciliation of drug treatments.
• •The patient is considered at risk of pneumococcal infection according to the recommendations of March 2017 of the High Council of Public Health (HCSP)
• •Pneumococcal vaccination is not up to date according to the HCSP 2017 recommendations.